MS, multiple sclerosis, 4397

N. diseases: 95; N. variants: 0
Disease: Progressive Neoplastic Disease ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0677932
Disease: Progressive Neoplastic Disease
Progressive Neoplastic Disease 		0.020 Biomarker phenotype BEFREE To evaluate the usability of serum GFAP measurement as a biomarker of progressive disease and disease severity in MS. 30570436 2020
CUI: C0677932
Disease: Progressive Neoplastic Disease
Progressive Neoplastic Disease 		0.020 Biomarker phenotype BEFREE Most of the current therapies, as well as many of the clinical trials, for multiple sclerosis (MS) target the inflammatory autoimmune processes, but less than 20% of all clinical trials investigate potential therapies for the chronic progressive disease stage of MS. 28105588 2017